Kopran Limited (BOM:524280)

India · Delayed Price · Currency is INR

199.65

+9.50 (5.00%)

At close: Aug 17, 2026

26.48% (1Y)

Market Cap	9.64B +26.5%
Revenue (ttm)	7.00B +12.0%
Net Income	249.83M -28.4%
EPS	5.17 -28.4%
Shares Out	48.29M
PE Ratio	38.59
Forward PE	n/a
Dividend	3.00 (1.58%)
Ex-Dividend Date	Aug 11, 2026

Volume	4,510
Open	197.00
Previous Close	190.15
Day's Range	191.15 - 199.65
52-Week Range	107.00 - 218.90
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, ur... [Read more]

Industry Pharmaceutical Preparations

Founded 1958

Employees 1,156

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524280

Full Company Profile

Financial Performance

In fiscal year 2026, Kopran's revenue was 6.81 billion, an increase of 8.23% compared to the previous year's 6.30 billion. Earnings were 257.31 million, a decrease of -33.26%.

Financial Statements